Financial News

Small Pharma Inc (OP:DMTTF)

N/A UNCHANGED

Last Price Updated: 3:59 PM EDT, Oct 20, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Small Pharma Inc

< Previous 1 2 3 4 5 6 7 8 Next >

Psychedelic Stock Gainers And Losers From January 18, 2022

January 18, 2022

GAINERS: Cybin (AMEX:

Via Benzinga

Marijuana & Psychedelic Drug Stocks Continue To Decline

January 16, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...

Via Talk Markets

Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High

January 09, 2022

There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.

Via Talk Markets

Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November

December 01, 2021

A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.

Via Talk Markets

Topics Cannabis

Exposures Cannabis

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021

November 08, 2021

Upgrades For Nektar Therapeutics (NASDAQ:

Via Benzinga

Compass Pathways 2.0: A New Rally In Psychedelic Stocks?

November 04, 2021

Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat?

Via Talk Markets

Topics Initial Public Offering

Exposures Securities Market

Small Pharma Receives European Patent Of Ketamine-Based Compounds For Treatment of Depressive Disorders

October 27, 2021

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), a neuropharmaceutical company focused on psychedelic-assisted therapies, announced on Tuesday, that it has received a European patent...

Via Benzinga

Topics Intellectual Property

Exposures Intellectual Property

Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent

October 26, 2021

The Week In Psychedelics

Via Benzinga

Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148%

October 24, 2021

The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD.

Via Talk Markets

Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?

October 23, 2021

The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.

Via Talk Markets

Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race

October 20, 2021

Small Pharma Inc. (OTCQB:DMTTF) (TSXV:

Via Benzinga

Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021

October 15, 2021

Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.

Via Talk Markets

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation

October 18, 2021

The Week In Psychedelics

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Small Pharma Inc (OP:DMTTF)

All News about Small Pharma Inc

Popular Pages